The largest database of trusted experimental protocols

7 protocols using chaps buffer

1

HER3 Activation and Inhibition Kinetics

Check if the same lab product or an alternative is used in the 5 most similar protocols
2 × 106 cells/dish were cultured at 37 °C for 24 h. After serum starvation in RPMI/1%serum with antibiotics for 24 h, cells were incubated with various compounds. For short kinetics, cells were stimulated with 100 ng/ml of NRG1 and/or incubated with 50 μg/ml of 9F7-F11 for 15 min to 3 h. For long kinetics, cells were incubated with 50 μg/ml of anti-HER3 antibody 9F7-F11 for 24 h to 120 h. After incubation, cells were washed, scraped and lysed with CHAPS buffer (Sigma-Aldrich), as indicated above. After washing in 1X PBS, the insoluble fraction was removed by centrifugation, and protein concentration in cell lysates was determined using the BCA assay. Two hundred micrograms of protein lysates were directly mixed with Laemmli buffer and heated at 95 °C for 5 min. After electrophoresis in reducing conditions, proteins were transferred to polyvinylidenedifluoride membranes (Millipore) and then incubated with the relevant primary and peroxidase-conjugated secondary antibodies, as previously described [33 (link)]. β-tubulin or β-actin were used as loading control.
+ Open protocol
+ Expand
2

Immunoblot analysis of BFV-infected cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cf2Th cells (canine fetal thymus cells, Cat. No. 90110521, European Collection of Authenticated Cell Cultures (ECACC), UK) were co-cultured with BFV100-infected Cf2Th cells in a proportion of 10 to 1 and grown in DMEM, supplemented with 10% fetal bovine serum in the 5% CO2 atmosphere. Three days after infection, when the cytopathic effect appeared, cells were lysed using a CHAPS buffer (0.5 M EDTA, 1 M Tris HCL pH 8.8, 100 mM NaCl, 0.5 M CHAPS, 0.5 M sodium deoxycholate; Sigma, Poznan, Poland). Uninfected Cf2Th cells were grown under the same condition. Of the total cell lysates, 10 µg of infected and uninfected control cells were separated by SDS-PAGE and served as the antigen for western blotting analyses (WB) [4 (link)]. Wild ruminant sera were used at 1:100 dilutions (v/v in 3% bovine albumin, 0.01% Tween 20, PBS) and Protein G–peroxidase conjugate (Sigma, Poznan, Poland) at 1:10,000 dilution. As positive and negative controls, the pools of serum samples from five BFV naturally infected cows and five uninfected animals, diagnosed by GST-ELISA and PCR tests [32 ], were used at 1:100 dilutions. ECL Plus reagents (GE Healthcare, Warsaw, Poland) were used for the detection of specifically bound antibodies.
+ Open protocol
+ Expand
3

RAGE-PRAK Interaction Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
CHO cells transfected with RAGE and GFP-tagged PRAK were washed with PBS and lysed with 1 % CHAPS buffer (Sigma). To reduce non-specific binding, pre-clearing with protein A/G agarose (Santa Cruz Biotechnology) was performed for 1 h at 4 °C with gentle rotating. After bicinchoninic acid assay, equal protein lysates were immunoprecipitated with anti-GFP antibodies (1 μg/mL; Santa Cruz Biotechnology), incubated overnight at 4 °C with gentle rotating, and added to the beads for 1 h. The samples were washed in the lysis buffer and elution protein complex with the SDS-PAGE sample loading buffer and analyzed by western blotting as described above. Brain tissue or SH-SY5Y cells were lysed with RIPA and using ImmunoCruz™ IP/WB Optima E System (Santa Cruz Biotechnology) according to the manufacturer’s protocol with anti-RAGE antibodies (1 μg/mL; Millipore).
+ Open protocol
+ Expand
4

Rat Abdominal Wall Decellularization Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole abdominal wall samples (n = 30) were decellularized using an already published protocol validated previously in our lab [40 (link)]. Whole rat abdominal wall samples were incubated with decellularization buffers under vigorous agitation at 150 rpm. The decellularization procedure involved the incubation of the samples in CHAPS buffer (pH 7; 8 mM CHAPS, 1 M NaCl, and 25 mM EDTA in PBS 1× (Sigma-Aldrich, Darmstadt, Germany) for 18 h at room temperature (RT). Next, the rat abdominal wall samples were washed 3 times (10 min each time) with PBS 1× (Sigma-Aldrich, Darmstadt, Germany) under continuous agitation (150 rpm) at RT. The samples were incubated in SDS buffer (pH 7; 1.8 mM SDS, 1 M NaCl, and 25 mM EDTA in PBS 1×; Sigma-Aldrich, Darmstadt, Germany) for another 18h at RT. The samples were again washed 3 times (10 min each time) with PBS 1× (Sigma-Aldrich, Darmstadt, Germany) under continuous agitation (150 rpm) at RT. Finally, the samples were placed in a solution containing a-Minimum Essentials Medium (a-MEM; Sigma-Aldrich, Darmstadt, Germany) supplemented with 40% v/v fetal bovine serum (FBS; Gibco, Thermo Fisher Scientific, Waltham, MA, USA) for 36 h at 37 °C and washed again, as described before. The whole decellularization procedure was repeated another 2 times (in total, 3 decellularization cycles, n = 5 samples/decellularization cycle).
+ Open protocol
+ Expand
5

Decellularization of Esophageal Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
rES (n = 10, l = 4 ± 1 cm) were cut into 3 segments of 1 cm and submitted to decellularization buffers. The decellularization process was performed according to previous described protocols with some modifications [12 (link),13 (link)]. Briefly the esophagus segments were subjected to CHAPS buffer at pH 7 (8 mM CHAPS, 1 M NaCl and 25 mM EDTA in PBS 1X, Sigma-Aldrich, Darmstadt, Germany) for 6 h at room temperature under constant agitation at 350 rpm. Then, the esophageal segments were subjected to SDS buffer at pH 7, (1.8 mM SDS, 1M NaCl and 25 mM EDTA in PBS 1X, Sigma-Aldrich, Darmstadt, Germany) for additional 6 h at room temperature under constant agitation at 350 rpm. Finally, the esophageal segments were incubated in α-Μinimum Essentials Medium (α-ΜΕM, Sigma-Aldrich, Darmstadt, Germany) supplemented with 40% v/v Fetal Bovine Serum (FBS, Sigma-Aldrich, Darmstadt, Germany) for 6 h at 37 °C under constant agitation at 350 rpm. The above procedure was repeated for 1 more cycle.
+ Open protocol
+ Expand
6

HER3 Immunoprecipitation and Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed in CHAPS buffer (Sigma-Aldrich) containing the protease inhibitor cocktail V (Calbiochem, Billerica, MA) and the phosphatase inhibitor cocktail II (Sigma-Aldrich). HER3 immunoprecipitation was performed by incubating 2 mg of cell lysate with 2 μg of the anti-HER3 antibody 2F12, which recognizes the HER3 intracellular C-terminal tail, at 4°C for 6 hr, followed by overnight incubation with 20 μl of protein A/G agarose beads (Santa Cruz Biotechnology) or with magnetic beads (Dynabeads; Life Technologies) at 4°C under agitation. Samples were washed five times with 400 μl CHAPS buffer, re-suspended in 100 μl of 2X SDS Laemmli buffer and heated at 90°C for 10 min before electrophoresis. In each case, no HER3 protein was immunoprecipitated with beads alone or with normal control IgG antibody.
+ Open protocol
+ Expand
7

Purifying MHC Class I Peptides

Check if the same lab product or an alternative is used in the 5 most similar protocols
Class I MHC molecules were immunoaffinity-purified from cell lines or tumors and their associated peptides were extracted as described previously(17 ). Cells (108–109) were lysed in 10 mL of CHAPS buffer (Sigma-Aldrich, St. Louis, MO) and the lysate was centrifuged at 100,000 × g for 1 hour at 4°C. Supernatants were passed over protein A-sepharose preloaded with HLA-B7 specific antibody (ME1). Peptides were eluted from the purified MHC class I molecules with 10% acetic acid and separated by ultrafiltration (Ultrafree-MC, Millipore, Billerica, MA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!